NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,083,140 | +1270.7% | 28,400 | +1320.0% | 0.30% | +2910.0% |
| Q3 2022 | $151,980 | -75.7% | 2,000 | -77.8% | 0.01% | -86.3% |
| Q2 2022 | $626,000 | -84.5% | 9,000 | -81.5% | 0.07% | -35.4% |
| Q1 2022 | $4,035,000 | -76.7% | 48,700 | -78.9% | 0.11% | -68.0% |
| Q4 2021 | $17,344,000 | +1392.6% | 231,000 | +2210.0% | 0.35% | +908.6% |
| Q3 2021 | $1,162,000 | -94.1% | 10,000 | -88.7% | 0.04% | -95.0% |
| Q2 2021 | $19,631,000 | – | 88,500 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |